The global home insemination products market is estimated to grow at a CAGR of 8.2% from 2024 to 2029 and the market size is predicted to be worth USD 5.97 billion by 2029 from USD 4.03 billion in 2024.
Home insemination is a fertilization technique that contains sperm placed into the female's reproductive tract using a syringe. This method is often suitable for lesbian couples, single women, and infertile couples. Most couples find it difficult when they try to conceive for the first time. These people prefer home insemination to in vitro fertilization (IVF). This procedure is done at home using an insemination kit that includes semen containers, ovulation tests, syringes, and other items to aid conception. Some kits include ovulation prediction kits because the technique is important over time, depending on the female menstrual cycle. Home insemination has several advantages, such as partner involvement, a relaxed environment, the use of fresh semen, high pregnancy rates, and the low cost of the procedure. Home insemination is allowed in most countries, but there are certain legalities of insemination that must be observed. However, there are no complete or perfect standards for home insemination. Currently, fertility law is strictly followed in developed countries like the United States and the United Kingdom.
The problem of infertility is one of the biggest and most serious concerns in the world that is developing among young people. The female preference for pregnancy and the gradual increase in the number of sub-fertile couples requiring assistance with pregnancy can be considered factors for the growth of the market. Age and egg quality in women and in women around 30 years old are expected to increase the demand for home insemination.
Changing lifestyles with an increasing focus of modern women on planned and reproductive life. Many modern career-oriented women delay motherhood due to an uninterrupted full-time career. This factor is driving the need for a home insemination product that drives market growth. Further, factors like low cost compared to other fertilization procedures and an increase in male infertility cases are the other factors supporting the market demand. However, the market is faced with some challenges, such as safety concerns, ethical concerns, and a high risk of transmission of STDs.
The use of the home insemination technique has increased in the population as infertility becomes more prevalent, increasing the preference of women for pregnancy and the rising number of subfertile couples who need help for pregnancy. Conception depends on a number of factors, such as age, quality of eggs, etc., and women in their 30s may find pregnancy to take longer. All of these factors have been attributed to the increased demand for home insemination around the world. The market for home insemination products is driven by the fact that it is a way to help people have children who otherwise could not conceive. In Western countries, many lesbian couples who wish to have a child are also opting for AI. Previously, couples opted for IVF treatment, but now they have realized the cheaper and easier alternative of home insemination at home or in the clinic. Other market drivers are more women choosing to become single mothers, advances in the technology of existing products, new products launched, etc.
However, the strict regulations that most countries put in place regarding who can receive fertility treatments are hampering the growth in the size of the global home insemination market. Some countries in Asia and the Middle East have strict family laws and have yet to pass laws on fertility and other related services. Hence, it is supposed to hamper the market growth during the forecast period.
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 to 2029 |
|
Base Year |
2023 |
|
Forecast Period |
2024 to 2029 |
|
CAGR |
8.2% |
|
Segments Covered |
By Product, Procedure Type, End-User, and Region |
|
Various Analyses Covered |
Global, Regional, and country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Analyst Overview of Investment Opportunities |
|
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
INVO Bioscience, Medgyn Products, Inc., Fujifilm Irvine Scientific., Kitazato Corporation, Rocket Medical plc, Genea Limited, Vitrolife, Rinovum Women's Health, LLC., and HI-TECH Solutions. |
The intrauterine insemination segment is expected to be the largest type of procedure in the market as it increases the fertilization rate by inserting sperm into a woman's uterus to facilitate fertilization.
Among these, the Insemination Kits segment is estimated to be the fastest growing in terms of value due to the growing geriatric population and is likely to generate higher revenue during the outlook period.
The fertility centers segment is anticipated to grasp the largest share of the worldwide market during the conjecture period. In addition, the main pharmaceutical companies are working on the launch of new insemination kits with conventional benefits. This is predicted to drive the growth of the global home insemination market.
Additionally, fertility issues are on the rise in the United States, ultimately fuelling the demand for home insemination in the region. For example, about 13% of women aged 16 to 45 in the United States have trouble getting pregnant.
The European market is anticipated to register a significant growth rate during the outlook period. This can be attributed to the unhealthy lifestyle and the increased prevalence of infertility. In addition, pregnancy delays and lifestyle changes are the major growth factors in the home insemination market in Europe.
The Asia-Pacific market is determined to dominate the home insemination market due to the increasing prevalence of infertility. For example, according to the Asian Pacific Journal of Reproduction, in 2019, in China, the infertility rate was 16% to 25% in women and 11% to 13% in men. Additionally, there is increased awareness of infertility treatment options, which is expected to drive the growth of the home insemination market in the region.
The market in the Middle East and Africa is foreseen to grow at a substantial rate due to the increasing rate of infertility in this locale.
The key players operating in the global home insemination market are INVO Bioscience, Medgyn Products, Inc., Fujifilm Irvine Scientific, Kitazato Corporation, Rocket Medical plc, Genea Limited, Vitrolife, Rinovum Women's Health, LLC and HI-TECH Solutions.
By Procedure
By Product Type
By End-User
By Region
Frequently Asked Questions
The global home insemination products market was valued at USD 3.44 bn in 2022.
The growing awareness about fertility issues, changing lifestyles, and the desire for more discreet options are majorly driving the growth of the home insemination products market.
The development of user-friendly, high-tech products, and a growing emphasis on inclusivity are some of the notable trends in the global market.
The market is expected to continue growing as more individuals and couples seek convenient and cost-effective fertility solutions.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region